Strides gets USFDA nod for Ibuprofen OTC oral suspension
February 24, 2021
×
Strides is focusing on building a private label business in the US by leveraging its portfolio of products across soft gels, tablets, capsules, topicals, powders and oral solutions
Strides Pharma Science Limited has announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte Limited, Singapore, has received approval for Ibuprofen Oral Suspension USP, 100 mg/5 mL (OTC) from the United States Food & Drug Administration (USFDA).
Ibuprofen OTC Oral Suspension Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain from various conditions such as headache, dental pain, and muscle aches. It is also used to reduce fever and to relieve minor aches and pains due to the common cold or flu. The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Children’s Motrin Oral Suspension, 100 mg/mL, of Johnson & Johnson Consumer Inc.